CardioGard received a 510(K) clearance for its Emboli Protection Cannula

January 11, 2015

We are pleased to announce that CardioGard, a Peregrine Ventures portfolio company, has received a 510(K) clearance for its Emboli protection cannula, and the device can now be imported into and marketed in the United States.

CardioGard is developing a specially designed arterial (aortic) cannula for use in cardiac surgery for the purpose of removal of gaseous and solid embolic material emanating from aortic manipulations. The cannula comprises a double lumen where the primary lumen provides oxygenated blood from the heart-lung machine to the patient and a secondary lumen suctions blood and embolic matter away from the surgical field and back to the cardiopulmonary bypass machine for filtration.




Please reload

Please reload

Recent Posts

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Maryland

October 15, 2019

Please reload

Featured Posts
Follow Us
Please reload

Search By Tags